SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001679363-24-000012
Filing Date
2024-02-22
Accepted
2024-02-22 07:04:41
Documents
16
Period of Report
2024-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K morf-20240222.htm   iXBRL 8-K 26566
2 EX-99.1 morf-20231231x8kex991.htm EX-99.1 70157
6 morphic_brandxrgb-extrasmaa.jpg GRAPHIC 30029
  Complete submission text file 0001679363-24-000012.txt   274038

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT morf-20240222.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT morf-20240222_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT morf-20240222_pre.xml EX-101.PRE 12516
17 EXTRACTED XBRL INSTANCE DOCUMENT morf-20240222_htm.xml XML 2723
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 (781) 996-0955
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38940 | Film No.: 24662255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)